An antimicrobial metabolite n- hexadecenoic acid from marine sponge-associated bacteria Bacillus subtilis effectively inhibited biofilm forming multidrug-resistant P. aeruginosa

References

• Papagianni M. 2003. Ribosomally synthesized peptides with antimicrobial properties: biosynthesis, structure, function, and applications. Biotechnol Adv. 21:465–499. doi:10.1016/s0734-9750(03)00077-6.
   PubMed Web of Science ®Google Scholar
• Bauer AW, Kirby WM, Sherris JC, Turck M. 1966. Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol. 45:493–496. doi:10.1093/ajcp/45.4_ts.493.
   PubMed Web of Science ®Google Scholar
• Bibi F, Faheem M, I Azhar E, Yasir M, A Alvi S, A Kamal M, Ullah I, I Naseer M. 2017. Bacteria from marine sponges: a source of new drugs. Curr Drug Metab. 18:11–15. doi:10.2174/1389200217666161013090610.
   PubMed Web of Science ®Google Scholar
• [CLSI] Clinical and Laboratory Standards Institute. 2012. Methods for dilution antimicrobial susceptibility tests for Bacteria that grow aerobically; Approved standard. – 9th Edition. CLSI document M07-A09/Wayne, PA: CLSI.
   Google Scholar
• Costerton JW, Stewart PS, Greenberg EP. 1999. Bacterial biofilms: a common cause of persistent infections. Science. 284:1318–1322. doi:10.1126/science.284.5418.1318.
   PubMed Web of Science ®Google Scholar
• Desbois AP, Smith VJ. 2010. Antibacterial free fatty acids: activities, mechanisms of action and biotechnological potential. Appl Microbiol Biotechnol. 85:1629–1642. doi:10.1007/s00253-009-2355-3.
   PubMed Web of Science ®Google Scholar
• Diomandé SE, Nguyen-The C, Guinebretière M-H, Broussolle V, Brillard J. 2015. Role of fatty acids in Bacillus environmental adaptation. Front Microbiol. 6:813. doi:10.3389/fmicb.2015.00813.
   PubMed Web of Science ®Google Scholar
• Enticknap JJ, Kelly M, Peraud O, Hill RT. 2006. Characterization of a culturable Alphaproteobacterial symbiont common to many marine sponges and evidence for vertical transmission via sponge larvae. Appl Environ Microbiol. 72:3724–3732. doi:10.1128/AEM.72.5.3724-3732.2006.
   PubMed Web of Science ®Google Scholar
• Fernebro J. 2011. Fighting bacterial infections-future treatment options. Drug Resist Updat. 14:125–139. doi:10.1016/j.drup.2011.02.001.
   PubMed Web of Science ®Google Scholar
• Gandhimathi R, Arunkumar M, Selvin J, Thangavelu T, Sivaramakrishnan S, Kiran GS, Shanmughapriya S, Natarajaseenivasan K. 2008. Antimicrobial potential of sponge associated marine actinomycetes. Journal de Mycologie Médicale. 18:16–22. doi:10.1016/j.mycmed.2007.11.001.
   Web of Science ®Google Scholar
• Gandhimathi R, Kiran GS, Hema TA, Selvin J, Raviji TR, Shanmughapriya S. 2009. Production and characterization of lipopeptide biosurfactant by a sponge-associated marine actinomycetes Nocardiopsis alba MSA10. Bioprocess Biosyst Eng. 32:825–835. doi:10.1007/s00449-009-0309-x.
   PubMed Web of Science ®Google Scholar
• Hallsworth JE, Magan N. 1997. A rapid HPLC protocol for detection of polyols and trehalose. J Microbiol Methods. 29:7–13. doi:10.1016/S0167-7012(97)00976-7.
   Web of Science ®Google Scholar
• Hassan A, Usman J, Kaleem F, Omair M, Khalid A, Iqbal M. 2011. Evaluation of different detection methods of biofilm formation in the clinical isolates. The Brazilian Journal of Infectious Diseases. 15:305–311. doi:10.1016/S1413-8670(11)70197-0.
   PubMed Web of Science ®Google Scholar
• Heydorn A, Nielsen AT, Hentzer M, Sternberg C, Givskov M, Ersboll BK, Molin S. 2000. Quantification of biofilm structures by the novel computer program COMSTAT. Microbiology. 146:2395–2407. doi:10.1099/00221287-146-10-2395.
   PubMed Web of Science ®Google Scholar
• Hirsch EB, Tam VH. 2010. Impact of multidrug-resistant Pseudomonas aeruginosa infection on patient outcomes. Expert Rev Pharmacoecon Outcomes Res. 10:441–451. doi:10.1586/erp.10.49.
   PubMed Web of Science ®Google Scholar
• Inoue T, Shingaki R, Fukui K. 2008. Inhibition of swarming motility of Pseudomonas aeruginosa by branched-chain fatty acids. FEMS Microbiol Lett. 281:81–86. doi:10.1111/j.1574-6968.2008.01089.x.
   PubMed Web of Science ®Google Scholar
• Janda JM, Atang-Nomo S, Bottone EJ, Desmond EP. 1980. Correlation of proteolytic activity of Pseudomonas aeruginosa with site of isolation. J Clin Microbiol. 12:626–628. doi:10.1128/jcm.12.4.626-628.1980.
   PubMed Web of Science ®Google Scholar
• Janßen HJ, Steinbüchel A. 2014. Fatty acid synthesis in Escherichia coli and its applications towards the production of fatty acid based biofuels. Biotechnol Biofuels. 7:7. doi:10.1186/1754-6834-7-7.
   PubMed Web of Science ®Google Scholar
• Jiang X, Zhang Z, Li M, Zhou D, Ruan F, Lu Y. 2006. Detection of extended-spectrum β-lactamases in clinical isolates of Pseudomonas aeruginosa. Antimicrob Agents Chemother. 50:2990–2995. doi:10.1128/AAC.01511-05.
   PubMed Web of Science ®Google Scholar
• Kiran GS, Jackson SA, Priyadharsini S, Dobson ADW, Selvin J. 2017. Synthesis of Nm-PHB (nanomelanin-polyhydroxy butyrate) nanocomposite film and its protective effect against biofilm-forming multi drug resistant Staphylococcus aureus. Sci Rep. 7:9167. doi:10.1038/s41598-017-08816-y.
   PubMed Web of Science ®Google Scholar
• Kiran GS, Lipton AN, Priyadharshini S, Anitha K, Suárez LEC, Arasu MV, Choi KC, Selvin J, Al-Dhabi NA. 2014. Antiadhesive activity of poly-hydroxy butyrate biopolymer from a marine Brevibacterium casei MSI04 against shrimp pathogenic vibrios. Microb Cell Fact. 13:114. doi:10.1186/s12934-014-0114-3.
   PubMed Web of Science ®Google Scholar
• Kiran GS, Priyadharshini S, Dobson ADW, Gnanamani E, Selvin J. 2016. Degradation intermediates of polyhydroxy butyrate inhibits phenotypic expression of virulence factors and biofilm formation in luminescent Vibrio sp. PUGSK8. NPJ Biofilms Microbiomes. 2:16002. doi:10.1038/npjbiofilms.2016.2.
   PubMed Web of Science ®Google Scholar
• Kiran GS, Priyadharsini S, Sajayan A, Ravindran A, Selvin J. 2018. An antibiotic agent pyrrolo[1,2-: a] pyrazine-1,4-dione,hexahydro isolated from a marine bacteria Bacillus tequilensis MSI45 effectively controls multi-drug resistant Staphylococcus aureus. RSC Adv. 8:17837–17846. doi:10.1039/C8RA00820E.
   PubMed Web of Science ®Google Scholar
• Kiran GS, Sabarathnam B, Selvin J. 2010. Biofilm disruption potential of a glycolipid biosurfactant from marine Brevibacterium casei. FEMS Immunol Med Microbiol. 59:432–438. doi:10.1111/j.1574-695X.2010.00698.x.
   PubMed Web of Science ®Google Scholar
• Kumar P, Lee JH, Beyenal H, Lee J. 2020. Fatty Acids as Antibiofilm and Antivirulence Agents. Trends Microbiol. 28:753–768. doi:10.1016/j.tim.2020.03.014.
   PubMed Web of Science ®Google Scholar
• Laport MS, Santos OCS, Muricy G. 2009. Marine sponges: potential sources of new antimicrobial drugs. Curr Pharm Biotechnol. 10:86–105. doi:10.2174/138920109787048625.
   PubMed Web of Science ®Google Scholar
• Levison ME. 2004. Pharmacodynamics of antimicrobial drugs. Infect Dis Clin North Am. 18:451–465, vii. doi:10.1016/j.idc.2004.04.012.
   PubMed Web of Science ®Google Scholar
• Lopes SP, Ceri H, Azevedo NF, Pereira MO. 2012. Antibiotic resistance of mixed biofilms in cystic fibrosis: impact of emerging microorganisms on treatment of infection. Int J Antimicrob Agents. 40:260–263. doi:10.1016/j.ijantimicag.2012.04.020.
   PubMed Web of Science ®Google Scholar
• Magiorakos A-P, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, Harbarth S, Hindler JF, Kahlmeter G, Olsson-Liljequist B, et al. 2012. Multidrug‐resistant, extensively drug‐resistant and pandrug‐resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 18:268–281. doi:10.1111/j.1469-0691.2011.03570.x.
   PubMed Web of Science ®Google Scholar
• Masadeh MM, Alzoubi KH, Ahmed WS, Magaji AS. 2019. In vitro comparison of antibacterial and antibiofilm activities of selected fluoroquinolones against Pseudomonas aeruginosa and methicillin-resistant Staphylococcus aureus. Pathogens. 8:12. doi:10.3390/pathogens8010012.
   PubMed Web of Science ®Google Scholar
• Mearns‐Spragg A, Bregu M, Boyd KG, Burgess JG. 1998. Cross‐species induction and enhancement of antimicrobial activity produced by epibiotic bacteria from marine algae and invertebrates, after exposure to terrestrial bacteria. Lett Appl Microbiol. 27:142–146. doi:10.1046/j.1472-765x.1998.00416.x.
   PubMed Web of Science ®Google Scholar
• Mensa J, Barberán J, Soriano A, Llinares P, Marco F, Cantón R, Bou G, del Castillo JG, Maseda E, Azanza JR. 2018. Antibiotic selection in the treatment of acute invasive infections by Pseudomonas aeruginosa: guidelines by the Spanish society of chemotherapy. Revista Española de Quimioterapia. 31:78.
   PubMed Web of Science ®Google Scholar
• Mesaros N, Nordmann P, Plésiat P, Roussel-Delvallez M, Van Eldere J, Glupczynski Y, Van Laethem Y, Jacobs F, Lebecque P, Malfroot A, et al. 2007. Pseudomonas aeruginosa: resistance and therapeutic options at the turn of the new millennium. Clin Microbiol Infect. 13:560–578. doi:10.1111/j.1469-0691.2007.01681.x.
   PubMed Web of Science ®Google Scholar
• Miller RD, Brown KE, Morse SA. 1977. Inhibitory action of fatty acids on the growth of Neisseria gonorrhoeae. Infect Immun. 17:303–312. doi:10.1128/iai.17.2.303-312.1977.
   PubMed Web of Science ®Google Scholar
• Mogana R, Adhikari A, Tzar MN, Ramliza R, Wiart C. 2020. Antibacterial activities of the extracts, fractions and isolated compounds from Canarium patentinervium Miq. against bacterial clinical isolates. BMC Complement Med Ther. 20:1–11. doi:10.1186/s12906-020-2837-5.
   PubMedGoogle Scholar
• Obritsch MD, Fish DN, MacLaren R, Jung R. 2005. Nosocomial infections due to multidrug‐resistant Pseudomonas aeruginosa: epidemiology and treatment options. Pharmacotherapy: the Journal of Human Pharmacology and Drug Therapy. 25:1353–1364. doi:10.1592/phco.2005.25.10.1353.
   Google Scholar
• Otsu N. 1979. A threshold selection method from gray-level histograms. IEEE Trans Syst, Man, Cybern. 9:62–66. doi:10.1109/TSMC.1979.4310076.
   Web of Science ®Google Scholar
• Pabel CT, Vater J, Wilde C, Franke P, Hofemeister J, Adler B, Bringmann G, Hacker J, Hentschel U. 2003. Antimicrobial activities and matrix-assisted laser desorption/ionization mass spectrometry of Bacillus isolates from the marine sponge Aplysina aerophoba. Mar Biotechnol (NY). 5:424–434. doi:10.1007/s10126-002-0088-8.
   PubMed Web of Science ®Google Scholar
• Prasath KG, Tharani H, Kumar MS, Pandian SK. 2020. Palmitic acid inhibits the virulence factors of Candida tropicalis: biofilms, Cell Surface Hydrophobicity, Ergosterol Biosynthesis, and Enzymatic Activity. Front Microbiol. 11: doi:10.3389/fmicb.2020.00864.
   PubMed Web of Science ®Google Scholar
• Santhakumari S, Nilofernisha NM, Ponraj JG, Pandian SK, Ravi AV. 2017. In vitro and in vivo exploration of palmitic acid from Synechococcus elongatus as an antibiofilm agent on the survival of Artemia franciscana against virulent vibrios. J Invertebr Pathol. 150:21–31. doi:10.1016/j.jip.2017.09.001.
   PubMed Web of Science ®Google Scholar
• Santhi LS, Prasad Talluri V, Nagendra SY, Krishna R. 2017. Bioactive compounds from marine sponge associates: Antibiotics from Bacillus sp. Nat Prod Chem Res. 05:4. doi:10.4172/2329-6836.1000266.
   Google Scholar
• Selvin J, Gandhimathi R, Kiran GS, Priya SS, Ravji TR, Hema TA. 2009. Culturable heterotrophic bacteria from the marine sponge Dendrilla nigra: isolation and phylogenetic diversity of actinobacteria. Helgol Mar Res. 63:239–247. doi:10.1007/s10152-009-0153-z.
   Web of Science ®Google Scholar
• Selvin J, Lipton AP. 2004. Dendrilla nigra, a marine sponge, as potential source of antibacterial substances for managing shrimp diseases. Aquaculture. 236:277–283. doi:10.1016/j.aquaculture.2004.01.021.
   Web of Science ®Google Scholar
• Shah DA, Wasim S, Abdullah FE. 2015. Antibiotic resistance pattern of Pseudomonas aeruginosa isolated from urine samples of Urinary Tract Infections patients in Karachi, Pakistan. Pak J Med Sci. 31:341.
   PubMed Web of Science ®Google Scholar
• Sharma G, Dang S, Gupta S, Gabrani R. 2018. Antibacterial activity, cytotoxicity, and the mechanism of action of bacteriocin from Bacillus subtilis GAS101. Med Princ Pract. 27:186–192. doi:10.1159/000487306.
   PubMed Web of Science ®Google Scholar
• Soares A, Alexandre K, Lamoureux F, Lemée L, Caron F, Pestel-Caron M, Etienne M. 2019. Efficacy of a ciprofloxacin/amikacin combination against planktonic and biofilm cultures of susceptible and low-level resistant Pseudomonas aeruginosa. J Antimicrob Chemother. 74:3252–3259. doi:10.1093/jac/dkz355.
   PubMed Web of Science ®Google Scholar
• Stehling EG, Silveira WDd, Leite DdS 2008. Study of biological characteristics of Pseudomonas aeruginosa strains isolated from patients with cystic fibrosis and from patients with extra-pulmonary infections. Braz J Infect Dis. 12:86–88. doi:10.1590/s1413-86702008000100018.
   PubMed Web of Science ®Google Scholar
• Stein T. 2005. Bacillus subtilis antibiotics: structures, syntheses and specific functions. Mol Microbiol. 56:845–857. doi:10.1111/j.1365-2958.2005.04587.x.
   PubMed Web of Science ®Google Scholar
• Strateva T, Yordanov D. 2009. Pseudomonas aeruginosa-A phenomenon of bacterial resistance. J Med Microbiol. 58:1133–1148. doi:10.1099/jmm.0.009142-0.
   PubMed Web of Science ®Google Scholar
• Tetz GV, Artemenko NK, Tetz VV. 2009. Effect of DNase and antibiotics on biofilm characteristics. Antimicrob Agents Chemother. 53:1204–1209. doi:10.1128/AAC.00471-08.
   PubMed Web of Science ®Google Scholar
• Thomas BT, Adeleke AJ, Raheem-Ademola RR, Kolawole R, Musa OS. 2012. Efficiency of some disinfectants on bacterial wound pathogens. Life Sci J. 9:752–755.
   Google Scholar
• Tsakona S, Papadaki A, Kopsahelis N, Kachrimanidou V, Papanikolaou S, Koutinas A. 2019. Development of a circular oriented bioprocess for microbial oil production using diversified mixed confectionery side-streams. Foods. 8(8):300. doi:10.3390/foods8080300.
   PubMed Web of Science ®Google Scholar
• Urdaci MC, Pinchuk I. 2004. Antimicrobial activity of Bacillus probiotics. Bacterial spore formers–Probiotics and emerging applications Norfolk, UK: horizon Bioscience.:171–182.
   Google Scholar
• Vijayanand S, Hemapriya J, Selvin J, Kiran S. 2012. Operational stability and reusability of Halobacterium sp. JS 1 Cells Immobilized in Various Matrices for Haloalkaliphilic Protease Production. 3:1–6.
   Google Scholar
• Wenderska IB, Chong M, McNulty J, Wright GD, Burrows LL. 2011. Palmitoyl‐DL‐carnitine is a multitarget inhibitor of Pseudomonas aeruginosa biofilm development. Chembiochem. 12:2759–2766. doi:10.1002/cbic.201100500.
   PubMed Web of Science ®Google Scholar
• Yff BTS, Lindsey KL, Taylor MB, Erasmus DG, Jäger AK. 2002. The pharmacological screening of Pentanisia prunelloides and the isolation of the antibacterial compound palmitic acid. J Ethnopharmacol. 79:101–107. doi:10.1016/s0378-8741(01)00380-4.
   PubMed Web of Science ®Google Scholar
• Yoon BK, Jackman JA, Valle-González ER, Cho N-J. 2018. Antibacterial free fatty acids and monoglycerides: biological activities, experimental testing, and therapeutic applications. IJMS. 19:1114. doi:10.3390/ijms19041114.
   Web of Science ®Google Scholar
• Young R, Gill JJ. 2015. MICROBIOLOGY. Phage therapy redux–What is to be done? Science. 350:1163–1164. doi:10.1126/science.aad6791.
   PubMed Web of Science ®Google Scholar